Similarly, in our own study of patients with inflammatory breast cancer, a rare and highly aggressive variant of breast cancer, we found that tumors with high NDRG1 expression were associated with worse overall and disease-specific survival compared with NDRG1-low tumors. This evidence concerns the gene NDRG1 and breast cancer.